Skip to content
Company Analysis

Utah Medical Products, Inc. UTMD

A comprehensive view of key metrics, scores, and financial health for Utah Medical Products, Inc.

Overview of Utah Medical Products, Inc.

UTMD NMS
Healthcare Medical Instruments & Supplies Micro Cap
Utah Medical Products, Inc. (UTMD), is a Micro Cap company, in the Medical Instruments & Supplies industry, last closed at $63.28, about 53.8% overvalued vs fair value, +9.2% 1Y return, placing in the top 10% of its sector.
$63.28
1.02%
As of March 13, 2026
Previous close • Vol 90d: 21.5%
52-Week Range
Market Cap
$208.60M
Enterprise Value
$123.08M
Overall Score
Scores locked

Create a free account to see overall and pillar scores for Utah Medical Products, Inc..

Top Beats

Quick Facts

Website https://www.utahmed.com
HQ Midvale, UT
Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull
$27
$29
$32
Current: $63.28 -54% vs base

Engine Room Money Flow™

Micro Cap

Corporate Free Cash Flow - Where revenue goes and how value is created

Flow Steps
Revenue
$38.5M
-5.8%%
Gross Profit
$19.9M
-17.7%%
Operating Income
$11.4M
-16.1%%
Net Income
$11.3M
-18.7%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Corporate Free Cash Flow

Quality & Reliability Indicators

Cash Conversion Ratio
129.3%
Excellent

FCF / Net Income - measures how well earnings convert to cash

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$24.2M
166.0% of FCF

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
1
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating Utah Medical Products, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
82
/100
Strong
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Moderate
71
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 97% Coverage
Trade-Off Triangle Visualization A ternary plot showing UTMD's balance between Growth (16.8%), Profitability (49.0%), and Safety (34.2%). Growth 17% Safety 34% Profitability 49%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

30th percentile vs peers
30
Key Signals
EPS Growth YoY -13.4% 40p EPS CAGR 3Y -0.7% 52p Rev Growth YoY -5.8% 23p TSR -31.2% 40p Revenue CAGR 3Y -9.7% 12p
Strengths
  • Interest Coverage Ratio in top 20% of peers (22.77, 87th percentile)
  • Superior capital returns - 3 return metrics above peer median
  • Operating Margin in top 20% of peers (29.6%, 96th percentile)
Risks

No significant risks identified for this axis.

Profitability

88th percentile vs peers
89
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

61th percentile vs peers
62
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Utah Medical Products, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$29.25
- - -
-53.8% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info